デフォルト表紙
市場調査レポート
商品コード
1593529

瘢痕治療の市場規模・シェア・成長分析 (製品別、瘢痕の種類別、治療の種類別、エンドユーザー別、地域別):産業予測 (2024~2031年)

Scar Treatment Market Size, Share, Growth Analysis, By Product (Creams, Gels), By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars), By Treatment Type, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 159 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
瘢痕治療の市場規模・シェア・成長分析 (製品別、瘢痕の種類別、治療の種類別、エンドユーザー別、地域別):産業予測 (2024~2031年)
出版日: 2024年11月14日
発行: SkyQuest
ページ情報: 英文 159 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の瘢痕治療の市場規模は、2022年に約20億5,000万米ドルと評価され、2023年の23億2,000万米ドルから、予測期間 (2024~2031年) に11.5%のCAGRで成長し、2031年には55億4,000万米ドルに達すると予測されています。

美容整形・再建処置市場は、美的魅力に対する社会的意識の高まり、事故や熱損傷の増加、革新的な治療機器の導入による急速な技術進歩など、さまざまな要因の組み合わせによって力強い成長が見込まれています。遠隔医療は、究極的には対面での診察が不可欠であることに変わりはありませんが、患者が自宅に居ながらにして医療専門家と接触することを可能にし、治療前後のプランニングの領域で支持を集めています。米国形成外科学会 (American College of Plastic Surgeons) によると、2022年には米国で約50,930件の瘢痕修復手術が実施されました。同時に、この市場は、特に、Qスイッチレーザーを利用して瘢痕組織を効果的に治療し、様々な医療分野で治癒を促進するMedLite C6のようなレーザー治療の取り入れを通じて、著しい技術的躍進を目の当たりにしています。これは外科的・非外科的応用の両方を包含し、形成再建外科はレーザー治療プログラムの重要な構成要素を形成しています。例えば、Cynosureが2022年6月に発売したPicoSure Pro Deviceは、しわ・にきび・しみの治療を目的とした画期的な技術革新です。こうした動向は全体的に、治療効果を高める医療技術の進歩と相まって、美観を改善したいという消費者の願望が市場の繁栄を牽引していることを示しています。

目次

イントロダクション

  • 分析目的
  • 定義
  • 市場範囲

分析手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場の概要と見通し
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • イノベーションマトリクス
  • 技術分析
  • ケーススタディ分析
  • 特許分析
  • 規制分析
  • バリューチェーン分析
  • 市場のエコシステム
  • 市場魅力度指数 (2023年)

瘢痕治療市場:製品別

  • 市場概要
  • 局所用製品
  • クリーム
  • ジェル
  • シリコンシート
  • その他
  • レーザー製品
  • クリーム
  • ジェル
  • シリコンシート
  • その他
  • 注射剤
  • その他

瘢痕治療市場:瘢痕の種類別

  • 市場概要
  • 萎縮性瘢痕
  • 肥厚性瘢痕・ケロイド瘢痕
  • 拘縮瘢痕
  • ストレッチマーク
  • その他

瘢痕治療市場:治療の種類別

  • 市場概要
  • 外科手術
  • レーザー
  • 局所薬
  • 注射薬

瘢痕治療市場:エンドユーザー別

  • 市場概要
  • 病院
  • クリニック
  • 在宅医療
  • その他

瘢痕治療市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ (MEA)
    • 湾岸協力会議 (GCC) 諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア (2023年)

主要企業プロファイル

  • Smith & Nephew PLC (英国)
  • Lumenis (イスラエル)
  • Merz Pharmaceuticals LLC (ドイツ)
  • Sonoma Pharmaceuticals Inc (米国)
  • Cynosure (米国)
  • Avita Medical Limited (オーストラリア)
  • HRA Pharma (フランス)
  • Polytech Health & Aesthetics GmbH (ドイツ)
  • Pacific World Corporation (米国)
  • CCA Industries, Inc. (米国)
  • Newmedical Technology Inc. (米国)
  • Molnlycke Health Care AB (スウェーデン)
  • Suneva Medical (米国)
  • Scar Heal Inc. (米国)
  • Pacific World Corporation (米国)
  • Perrigo Company plc (アイルランド)
  • Sientra, Inc (米国)
  • Bausch Health Companies, Inc. (カナダ)
  • Scarguard (米国)
  • Bio-Oil (南アフリカ)
目次
Product Code: SQMIG35A2949

Global Scar Treatment Market size was valued at around USD 2.05 billion in 2022 and is expected to rise from USD 2.32 billion in 2023 to reach a value of USD 5.54 billion by 2031, at a CAGR of 11.5% over the forecast period (2024-2031).

The market for aesthetic and reconstructive procedures is poised for robust growth driven by a combination of factors including rising societal awareness of aesthetic appeal, an increase in accidents and thermal injuries, and rapid advancements in technology that introduce innovative treatment devices. Telemedicine has gained traction in the realm of pre-and post-treatment planning, allowing patients to engage with healthcare professionals from the comfort of their homes, although in-person consultations remain essential for ultimate treatment. According to the American College of Plastic Surgeons, around 50,930 scar repair procedures were conducted in the U.S. in 2022, reflecting a growing demand for procedures aimed at enhancing physical appearance. Concurrently, the market is witnessing significant technological breakthroughs, notably through the incorporation of laser therapies like the MedLite C6, which utilizes Q-switched lasers to effectively treat scar tissue and promote healing across various medical fields. This encompasses both surgical and non-surgical applications, with plastic reconstructive surgery forming a vital component of laser treatment programs. For instance, Cynosure's launch of the PicoSure Pro Device in June 2022 marks a groundbreaking innovation aimed at treating wrinkles, acne, and blemishes. Overall, these trends indicate a thriving market driven by consumer desires for improvement in aesthetics, coupled with advancing medical technology that enhances treatment efficacy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Scar Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Scar Treatment Market Segmental Analysis

Global Scar Treatment Market is segmented by Product, Scar Type, Treatment Type, End-User and Region. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products (CO2 Laser, Pulse-dyed Laser, and Others), Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, Stretch Marks, and Others. Based on Treatment Type, the market is segmented into Surgical, Laser, Topical, and Injectable. Based on End User, the market is segmented into Hospitals, Clinics, Homecare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Scar Treatment Market

The global scar treatment market is significantly driven by the rising demand for aesthetic solutions, as individuals become increasingly conscious of their appearance amidst growing societal focus on physical beauty. This heightened awareness has led to a surge in the quest for effective treatments to minimize scar visibility. Furthermore, the increasing disposable income across both advanced and emerging economies has broadened access to these treatments, making them more attainable for a larger demographic. Additionally, social media influence and celebrity endorsements of aesthetic procedures have further heightened awareness, creating a robust demand for innovative scar treatment options and contributing to market growth.

Restraints in the Global Scar Treatment Market

One of the significant restraints impacting the Global Scar Treatment market is the prohibitive cost associated with advanced scar removal therapies, particularly laser treatments and surgical revisions. These high-priced options, while often the most effective for severe scarring, create substantial financial barriers for patients, especially in developing regions or among lower-income populations. Over-the-counter (OTC) topical treatments, although more affordable, frequently lack efficacy for deep, severe wounds, compelling many to forgo optimal care. This disparity in access to quality scar management solutions not only limits market growth but also reinforces the need for more economically viable treatment alternatives across diverse demographics.

Market Trends of the Global Scar Treatment Market

The Global Scar Treatment market is witnessing a significant trend towards technological advancements, particularly in laser wound treatment. The adoption of laser-based therapies has surged due to their precision in targeting scar tissue at varying depths, promoting effective skin renewal while minimizing damage to surrounding healthy skin. Innovations in laser technology have enhanced patient outcomes by significantly reducing the visibility of scars and accelerating healing times. As patients increasingly seek less invasive and more effective treatment options, the demand for sophisticated laser therapies is expected to drive market growth, positioning the industry for continued expansion fueled by ongoing research and development.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Innovation Matrix
  • Technology Analysis
  • Case Study Analysis
  • Patent Analysis
  • Regulatory Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Market Attractiveness Index, 2023

Scar Treatment Market, By Product

  • Market Overview
  • Topical Products
  • Creams
  • Gels
  • Silicon Sheets
  • Others
  • Laser Products
  • Creams
  • Gels
  • Silicon Sheets
  • Others
  • Injectables
  • Others

Scar Treatment Market, By Scar Type

  • Market Overview
  • Atrophic Scars
  • Hypertrophic & Keloid Scars
  • Contracture Scars
  • Stretch Marks
  • Others

Scar Treatment Market, By Treatment Type

  • Market Overview
  • Surgical
  • Laser
  • Topical
  • Injectable

Scar Treatment Market, By End User

  • Market Overview
  • Hospitals
  • Clinics
  • Homecare
  • Others

Scar Treatment Market, by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Smith & Nephew PLC (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lumenis (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Pharmaceuticals LLC (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonoma Pharmaceuticals Inc (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cynosure (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avita Medical Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HRA Pharma (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polytech Health & Aesthetics GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific World Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CCA Industries, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Newmedical Technology Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molnlycke Health Care AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suneva Medical (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Scar Heal Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific World Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sientra, Inc (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch Health Companies, Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Scarguard (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Oil (South Africa)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments